1. Home
  2. CSWC vs ETON Comparison

CSWC vs ETON Comparison

Compare CSWC & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Capital Southwest Corporation

CSWC

Capital Southwest Corporation

HOLD

Current Price

$25.47

Market Cap

1.6B

ML Signal

HOLD

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$59.82

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSWC
ETON
Founded
1961
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.3B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
CSWC
ETON
Price
$25.47
$59.82
Analyst Decision
Buy
Strong Buy
Analyst Count
5
3
Target Price
$23.50
$39.33
AVG Volume (30 Days)
588.2K
609.9K
Earning Date
05-13-2026
05-14-2026
Dividend Yield
10.89%
N/A
EPS Growth
29.25
N/A
EPS
0.39
0.41
Revenue
$10,835,000.00
$79,950,000.00
Revenue This Year
$17.45
$40.90
Revenue Next Year
$10.26
$47.23
P/E Ratio
$65.13
$152.85
Revenue Growth
16.08
104.94
52 Week Low
$19.37
$14.27
52 Week High
$25.48
$66.37

Technical Indicators

Market Signals
Indicator
CSWC
ETON
Relative Strength Index (RSI) 70.24 63.82
Support Level $22.76 $15.66
Resistance Level N/A N/A
Average True Range (ATR) 0.27 3.49
MACD 0.04 0.32
Stochastic Oscillator 99.58 76.18

Price Performance

Historical Comparison
CSWC
ETON

About CSWC Capital Southwest Corporation

Capital Southwest Corp is a U.S.-based investment company that specializes in providing customized financing to middle market companies across various industries. The company's investment objective is to produce attractive risk-adjusted returns by generating current income from debt investments and capital appreciation from equity and equity related investments. It focuses on providing flexible financing solutions through partnerships with business owners, management teams, and financial sponsors. The company's portfolio may include senior debt, second lien, and subordinated debt, preferred stocks, common stocks, and warrants. The primary source of revenue comprises interest income and dividend income from investments made as well as management fees.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.

Share on Social Networks: